References
- Rasbury WC. Attention deficit disorder: an overview. Henry Ford Hosp Med J 1988; 36(4): 212–6
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: Am Psychiatric Assn, 1994
- Safer DJ, Krager JM. Trends in the medication treatment of hyperactive school children. Clin Pediatr (Phila) 1983; 22(7): 500–4
- Kavale K. The efficacy of stimulant drug treatment for hyperactivity: a meta-analysis. J Learn Disabil 1982; 15(5): 280–9
- Rapoport JL, Buchsbaum MS, Weingartner H, et al. Dextroamphetamine: its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 1980; 37(8): 933–43
- Nehra A, Mullick F, Ishak KG, et al. Pemoline-associated hepatic injury. Gastroenterology 1990; 99(5): 1517–9
- Physicians' desk reference. 50th ed. Montvale, NJ: Medical Economics Data, 1996: 848, 2476
- Davy T, Rodgers CL. Stimulant medication and short attention span: a clinical approach. J Dev Behav Pediatr 1989; 10(6): 313–8
- Birmaher B, Greenhill LL, Cooper TB, et al. Sustained release methylphenidate: pharmacokinetic studies in ADHD males. J Am Acad Child Adolesc Psychiatry 1989; 28(5): 768–72
- Pelham WE Jr, Greenslade KE, Vodde-Hamilton M, et al. Relative efficacy of long-acting stimulants on children with attention-deficit hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 1990; 86(2): 226–37
- Kessler S. Drug therapy in attention deficit hyperactivity disorder. South Med J 1996; 89(1): 33–8
- Spencer T, Biederman J, Wilens T. Tricyclic antidepressant treatment of children with ADHD and tic disorders. J Am Acad Child Adolesc Psychiatry 1994; 33(8): 1203–4
- Wilens TE, Biederman J, Spencer T. Clonidine for sleep disturbances associated with attention-deficit hyperactiviry disorder. J Am Acad Child Adolesc Psychiatry 1994; 33(3): 424–6
- Hunt RD, Amsten AF, Asbell MD. An open trial of guanfacine in the treatment of atrention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995; 34(1): 50–4
- Barrickman L, Noyes R, Kuperman S, et al. Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 1991; 30(5): 762–7
- Gammon GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 1993; 3(1): 1–10
- Barrickman LL, Perry PJ, Allen AJ, et al. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995; 34(5): 649–57
- Rossiter TR, La Vaque TJ. A comparison of EEG biofeedback and psychostimulants in treating attention deficit/hyperactivity disorders. J Neurother 1995; 2: 48–59
- Niemann H, Ruff RM, Baser CA. Computer-assisted attention retraining in head-injured individuals: a controlled efficacy study of an outpatient program. J Consult Clin Psychol 1990; 58(6): 811–7
- Scheinbaum S, Newton CJ, Zecker S, et al. A controlled study of EEG biofeedback as a treatment for attention-deficit disorders. Abstract. Proceedings of the 26th Annual Meeting. Association for Applied Psychophysiology and Biofeedback. Biofeedback and Self-Regulation 1995; 20(3): 295–6